US$ 24.00
glucagon like peptide 1 glp 1 drugs Glucagon-like (9-36) - GLP-1 Amide Discovery of GLP-1–Based Drugs for
Description
Although, in the last 10 years, the use of GLP-1 RAs, especially semaglutide and liraglutide, has increased, its clinical implications and how it affects metabolic parameters have yet to be fully consolidated

As the popularity of GLP-1 drugs continues to skyrocket, there has also been a huge rise in overdoses

Among the marketed large molecule injectable GLP-1 agonists, semaglutide, apart from weight-loss, is being studied for kidney disease and tirzepatide (a dual GLP-1 and GIP receptor agonist) is being evaluated for sleep apnea in Ph 3 clinical trials

However, the cost of sitagliptin and the need for more data may restrict its use

Women with T2DM have a similarly high risk for pregnancy complications as pregnant women with type 1 diabetes...

That best hormone
